Eloxx Pharmaceuticals, Inc. (ELOX) - The clinical-stage biopharmaceutical company's shares surged nearly 50% on Wednesday after-hours trade. The company announced that enrollment in its Phase 2 clinical trial for ELX-02 in cystic fibrosis has been resumed in Israel and Europe after being temporarily paused in response to the COVID-19 pandemic.
from RTT - Earnings https://ift.tt/30QI7uv
via IFTTT
No comments:
Post a Comment